key: cord-1047475-zyt8h1pm authors: Alizad-Rahvar, A. R.; Sadeghi, M. title: Effect of asymptomatic transmission and emergence time on multi-strain viral disease severity date: 2021-04-23 journal: nan DOI: 10.1101/2021.04.18.21255684 sha: 4f8c48932f56201a3d798ee243ef64f7fbd06ff3 doc_id: 1047475 cord_uid: zyt8h1pm Background: In a viral epidemic, the emergence of a novel strain with increased transmissibility (larger value of basic reproduction number R0) sparks the fear that the increase in transmissibility is likely to lead to an increase in disease severity. It is required to investigate if a new, more contagious strain will be necessarily dominant in the population and resulting in more disease severity. Methods: The impact of the asymptomatic transmission and the emergence time of a more transmissible variant of a multi-strain viral disease on the disease prevalence, disease severity, and the dominant variant in an epidemic was investigated by a proposed 2-strain epidemic model, called 2-SEICARD model, that is an extension of the SEIRD model. Results: The simulation results showed that considering only R0, is insufficient to predict the outcome of a new, more contagious strain in the population. A more transmissible strain with a high fraction of asymptomatic cases can substantially reduce the mortality rate. If the emergence time of the new strain is closer to the start of the epidemic, the new, more contagious variant has more chance to win the viral competition and be the dominant strain; otherwise, despite being more contagious, it cannot dominate previous strains. Conclusions: Three factors of R0, the fraction of asymptomatic transmission, and the emergence time of the new strain are required to correctly determine the prevalence, disease severity, and the winner of the viral competition. The emergence of the novel coronavirus strain in the UK, called SARS-CoV-2 VOC 202012/01 or B.1.1.7, was shocking because this novel variant could be up to about 70% more transmissible than pre-existing variants of SARS-CoV-2 1 . This increased transmissibility can add between 0.4 and 0.7 to the basic reproduction number R 0 . This news sparked the fear that the increase in transmissibility is likely to lead to a large increase in hospitalization, intensive care unit (ICU) admission rate, and mortality. However, the studies about previous variants of SARS-CoV-2 showed that despite the rise of the lab-confirmed cases, the COVID-19 case fatality rate (CFR) declined, i.e., more transmissibility did not necessarily cause more severity 2, 3 . Other studies in the UK and England showed that besides increasing the COVID-19 cases, the hospitalization rate, the ICU admission rate, and the CFR declined 4, 5 . The preliminary explanation was the predominant shift towards positivity in younger age groups who have a better outcome. However, the analysis of German COVID-19 data 6 , which was reported by age categories, showed that the COVID-19 CFR declined across all age groups 7 . Interestingly, the older groups drove the overall reduction in CFR. The public health authorities need to pinpoint the cause of this decline in the fatality rate in order to decide how to react against the newly emerged viral strains. The decision to fight blindly against a novel strain because of its increased transmissibility is not necessarily the most comprehensive and effective solution. We need to take other factors along with the transmissibility into account in our decision-making. The spread of COVID-19 is an iceberg with the invisible part of being the asymptomatic transmission. The percent of asymptomatic cases who never experience COVID-19 symptoms remains uncertain. From about 20% to 50% of infected people are reported to be asymptomatic [8] [9] [10] . In a study, 39% of children aged 6-13 years tested positive for COVID-19 with no symptoms 11 . Different studies reported an insignificant difference in the upper respiratory viral load between symptomatic and asymptomatic cases 8, 12 . Even a new study found that asymptomatic patients had higher SARS-CoV-2 viral loads than symptomatic cases 13 . Consequently, the asymptomatic infected people could play a significant driver role in the community spread of COVID-19. The results of a study demonstrated that both R 0 and the proportion of asymptomatic transmissions were the main factors in controlling an infectious disease outbreak 14 . In this study, we investigate the effect of the emergent viral strain on the total number of infected people and the illness severity by using epidemiological modeling. We will show that in an epidemic situation, the emergence time of the new strain and the relative R 0 of the primary and the emergent strains determine the winner of the competition between two viral strains. Moreover, we will see that the disease severity and the mortality rate can be significantly influenced by the emergence time and the fraction of asymptomatic infectious cases of the emergent strain. For each viral strain, we use the extended version of the classic SEIRD epidemic model, called the SEICARD model, consisting of susceptible (S), exposed (in the latent period) (E), symptomatic infected (I), critically infected (C), asymptomatic infected (A), recovered (R), and dead (D) people. By paralleling two SEICARD models, we develop a 2-strain model, called 2-SEICARD, that describes the existence and competition of two viral variants in the population (Fig. 1 ). The index s = 1 or 2 in E s , I s , C s , A s , R s , and D s represents the infectious strain in each group. It is assumed that the emergence time of the second strain is T E days after the emergence time of the primary one, which is day 0. Moreover, we assume that there is no viral superinfection, i.e., the reinfection or co-infection between variants does not occur. In other words, the recovered individuals are cross-immunized and are immune to the new variants. The parameters of the 2-SEICARD model are explained in Table I . The ODE system of this 2-strain model is given by for s = 1 and 2. Here, the total population is N = S + 2 s=1 (E s + I s + C s + A s + R s + D s ). For simplicity, the natural birth and death rates are ignored in the model. To implement the emergence time T E , we set all parameters of the second strain to zero for t < T E . For each strain, the infection rates β I s , β C s , and β A s denote the probability of transmitting disease from I s , C s , or A s to S, respectively. On the other hand, as Fig. 1 shows, the outcome of each All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2021. ; https://doi.org/10.1101/2021.04.18.21255684 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2021. ; https://doi.org/10.1101/2021.04.18.21255684 doi: medRxiv preprint exposed person E s could be A s , I s , C s , and D s with the probabilities of P A s , (1 − P A s )(1 − P C s ), (1 − P A s )P C s (1 − P D s ), and (1 − P A s )P C s P D s , respectively. By using the method of next-generation matrices 15 , we can obtain the following expression for the R 0 of each strain where R Table I . In our modeling, we assume a wild animal population in which there is no isolation and social policy or restriction. Hence, we consider that all I s , C s , and A s outcomes have the same probability of transmission; i.e., β I s = β C s = β A s . According to Eq. In this section, we consider fixed parameters for the first strain in the 2-SEICARD model; i.e., R In all the above scenarios, we study the effect of the emergent strain on the total number of infected cases and the mortality rate, as a measure of severity, from the beginning of the epidemic until we reach the endemic steady state. The total number of infected cases is N − S ∞ , where S ∞ denotes the number of susceptible cases that have not been infected at all when the disease has gone. The mortality rate is the total proportion of deaths in the population due to infection. The simulation results show that the total number of infected cases does not vary with P A 2 for the fixed values of R 0 , the emergent strain does not have any chance to compete with the primary strain and would become extinct immediately (see Fig. 2(A1) ). In the case of R (2) 0 = R (1) 0 , the total number of infected cases with two strains remains the same as that in the case of spreading only the primary strain in the population with the same value of the basic reproduction number. Moreover, Fig. 2(A2) demonstrates that the total number of infected cases does not vary with the emergence time of the second strain, T E . However, the later emergence of strain 2 results in less proportion of infection with this strain in the population. In contrast, Fig. 2 (A3) depicts that the emergence of a more contagious strain (R (2) 0 > R (1) 0 ) increases the total number of infected cases compared to the existence of only the primary strain. Furthermore, Fig. 2(A3) shows that the new, more contagious strain with larger value of R 0 does not necessarily dominate in the population. In other words, R 0 alone does not determine which virus wins the viral competition. Indeed, besides the values of R 0 , the emergence time T E also determines whether the new strain with more transmissibility dominates the primary one or not. The sooner emergence of the new, more contagious variant can make it dominant; otherwise, the primary strain remains dominant in the population. Our main question is that in the case of R 0 , whether or not more infected cases increase similarly the mortality rate of the disease or not. To answer this question, consider the mortality All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2021. ; https://doi.org/10.1101/2021.04.18.21255684 doi: medRxiv preprint 0 , the emergent strain cannot compete with the primary strain, and hence, the mortality All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 23, 2021. ; https://doi.org/10.1101/2021.04.18.21255684 doi: medRxiv preprint rate remains fixed for all values of P A 2 , equal to the mortality rate of the primary strain alone. Hence, in these figures, although blue curves are corresponding to the 2-strain scenario, they also represent the mortality rate of the primary strain alone. As we expected, provided that R and P A 1 = P A 2 , the mortality rate remains the same as that of the primary strain alone. On the other hand, as Fig. 2 (B1) depicts, if both strains have a similar proportion of asymptomatic cases, i.e., P A 1 = P A 2 , the mortality rate increases with the emergence of a more contagious strain (R (2) 0 > R (1) 0 ). In this case, the sooner that the new strain emerges, the more in the mortality rate increases. However, as Figures 2(B2-B3) show, the increase in P A 2 can reduce the mortality rate for R 0 . For large values of P A 2 , although a more contagious strain emerges, it can make the mortality rate less than that before the emergence (Fig. 2(B3) ). Interestingly, for large values of P A 2 , the emergent strain with higher R 0 decreases the mortality rate more. In other words, more transmissibility does not reflect necessarily more severity, and both R (s) 0 and P A s values should be considered to correctly determine the effect of the more transmissible new strain on the viral disease severity. In this study, we investigated the impact of the asymptomatic transmission and the emergence time of the new, more contagious viral strain on the disease prevalence, disease severity, and the dominant variant in an epidemic. Our results demonstrated that being an emergent strain with more transmissibility, i.e., having a larger basic reproduction number R 0 , compared to previous variants, does not necessarily lead to more severity or mean that the new variant will dominate in the population. Indeed, when a new strain with a larger basic reproduction number emerges, it will increase the number of infected cases in the population. However, the creation of more severe outcomes depends on the fraction of asymptomatic transmissions. If a large proportion of infections, due to the new variant, do not show any symptom, they can even reduce the mortality rate in the population. Moreover, provided that the emergence time of the new strain is closer to the start of the epidemic, the new, more contagious variant has more chance to win the viral competition and be the dominant strain; otherwise, despite being more contagious, it cannot dominate previous strains. Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv -2 Variants Why do COVID death rates seem to be falling? COVID-19: Declining Admissions to Intensive Care Units The Declining Case Fatality Ratio in England Declining COVID-19 Case Fatality Rates across all ages: analysis of German data Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection Spread of SARS-CoV-2 in the Icelandic Population Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study. Clinical Infectious Diseases The early phase of the COVID-19 outbreak in Lombardy, Italy. arXiv. 2020 Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg. Infection Factors that make an infectious disease outbreak controllable The construction of next-generation matrices for compartmental epidemic models The authors would like to thank A. Kalirad for constructive discussion that contributed to the development of this research.